Cidara Therapeutics, Inc. (CDTX)
USD 20.53
(-10.0%)
USD 20.53
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 63.9 Million | 64.28 Million | 49.57 Million | 12.06 Million | 20.91 Million | - |
| Cost of Revenue | 1.52 Million | 143 Thousand | 189 Thousand | 68.01 Million | 46.4 Million | 523 Thousand |
| Gross Profit | 62.38 Million | 64.14 Million | 49.38 Million | -55.95 Million | -25.48 Million | -523 Thousand |
| Operating Expenses | 86.86 Million | 94 Million | 91.82 Million | 83.91 Million | 62.63 Million | 63.28 Million |
| Selling, General and Administrative Expenses | 18.33 Million | 18.48 Million | 18.74 Million | 15.89 Million | 16.23 Million | 14.14 Million |
| Research and Development Expenses | 68.53 Million | 75.52 Million | 73.08 Million | 68.01 Million | 46.4 Million | 49.14 Million |
| Other Expenses | - | - | - | - | - | -211 Thousand |
| Cost and Expenses | 88.38 Million | 94 Million | 91.82 Million | 83.91 Million | 62.63 Million | 63.28 Million |
| Operating Income | -24.48 Million | -29.71 Million | -42.25 Million | -71.84 Million | -41.72 Million | -63.28 Million |
| Interest Expense | - | 191 Thousand | 212 Thousand | 262 Thousand | 221 Thousand | 629 Thousand |
| Income Tax Expense | 443 Thousand | 272 Thousand | 1.44 Million | 262 Thousand | -1 Million | 4.26 Million |
| Earnings before Tax | -22.48 Million | -29.52 Million | -42.46 Million | -72.11 Million | -41.09 Million | -59.01 Million |
| Net Income | -22.93 Million | -29.79 Million | -43.9 Million | -72.37 Million | -40.08 Million | -59.01 Million |
| Earnings Per Share Basic | -5.25 | -8.53 | -16.75 | -34.83 | -26.78 | -45.62 |
| Earnings Per Share Diluted | -5.25 | -8.53 | -16.74 | -34.83 | -26.78 | -45.62 |
| Weighted Average Shares Outstanding | 4.37 Million | 3.49 Million | 2.62 Million | 2.07 Million | 1.49 Million | 1.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.37 Million | 3.49 Million | 2.62 Million | 2.07 Million | 1.49 Million | 1.29 Million |
| Gross Margin | 0.98 | 1.00 | 1.00 | -4.64 | -1.22 | - |
| EBIT Margin | -0.38 | -0.46 | -0.85 | -5.94 | -2.01 | - |
| Profit Margin | -0.36 | -0.46 | -0.89 | -6.00 | -1.92 | - |
| EBITDA | -24.36 Million | -33.36 Million | -42.25 Million | -71.56 Million | -41.39 Million | -62.76 Million |
| Earnings Before Tax Margin | -0.38 | -0.46 | -0.85 | -5.95 | -1.99 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 302 Thousand | 8.46 Million | 17.58 Million | 63.9 Million | 12.71 Million | 7.61 Million |
| Cost of Revenue | 57 Thousand | 1.56 Million | 1.13 Million | 1.52 Million | 387 Thousand | 401 Thousand |
| Gross Profit | 245 Thousand | 6.9 Million | 16.44 Million | 62.38 Million | 12.33 Million | 7.21 Million |
| Operating Expenses | 11.34 Million | 17.59 Million | 22.52 Million | 86.86 Million | 20.88 Million | 20.44 Million |
| Selling, General and Administrative Expenses | 4.68 Million | 5.99 Million | 7.16 Million | - | 3.55 Million | 3.31 Million |
| Research and Development Expenses | 6.65 Million | 11.59 Million | 15.35 Million | - | 17.33 Million | 17.13 Million |
| Other Expenses | 84.88 Million | - | - | - | - | - |
| Cost and Expenses | 11.4 Million | 19.15 Million | 23.65 Million | 88.38 Million | 21.27 Million | 20.44 Million |
| Operating Income | -11.1 Million | -10.69 Million | -6.07 Million | -24.48 Million | -8.55 Million | -12.83 Million |
| Interest Expense | - | - | - | - | - | 623 Thousand |
| Income Tax Expense | -4.8 Million | -56 Thousand | 64 Thousand | 443 Thousand | -230 Thousand | 149 Thousand |
| Earnings before Tax | -94.21 Million | -10.32 Million | -5.54 Million | -22.48 Million | -7.94 Million | -12.2 Million |
| Net Income | -89.41 Million | -10.32 Million | -5.61 Million | -22.93 Million | -8.17 Million | -12.35 Million |
| Earnings Per Share Basic | -19.59 | -2.28 | -1.25 | - | -1.81 | -2.80 |
| Earnings Per Share Diluted | -19.59 | -2.28 | -1.24 | - | -1.81 | -2.74 |
| Weighted Average Shares Outstanding | 4.56 Million | 4.53 Million | 4.49 Million | 4.37 Million | 4.51 Million | 4.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.56 Million | 4.53 Million | 4.52 Million | 4.37 Million | 4.51 Million | 4.5 Million |
| Gross Margin | 0.81 | 0.82 | 0.94 | 0.98 | 0.97 | 0.95 |
| EBIT Margin | -36.57 | -1.26 | -0.34 | - | -0.67 | -1.69 |
| Profit Margin | -296.06 | -1.22 | -0.32 | -0.36 | -0.64 | -1.62 |
| EBITDA | -11.04 Million | -10.69 Million | -6.03 Million | - | -8.55 Million | -12.83 Million |
| Earnings Before Tax Margin | -36.76 | -1.26 | -0.35 | -0.38 | -0.67 | -1.69 |
JOSTS
JAIBALAJI
009420
002547
2364
INSPIRISYS